Author:
Simbeye Atusaye J.,Kumwenda Save,Cohee Lauren M.,Omondi Dickens,Masibo Peninah K.,Wao Hesborn,Awandu Shehu S.
Abstract
Abstract
Background
Malaria remains a significant global health burden affecting millions of people, children under 5 years and pregnant women being most vulnerable. In 2019, the World Health Organization (WHO) endorsed the introduction of RTS,S/AS01 malaria vaccine as Phase IV implementation evaluation in three countries: Malawi, Kenya and Ghana. Acceptability and factors influencing vaccination coverage in implementing areas is relatively unknown. In Malawi, only 60% of children were fully immunized with malaria vaccine in Nsanje district in 2021, which is below 80% WHO target. This study aimed at exploring factors influencing uptake of malaria vaccine and identify approaches to increase vaccination.
Methods
In a cross-sectional study conducted in April–May, 2023, 410 mothers/caregivers with children aged 24–36 months were selected by stratified random sampling and interviewed using a structured questionnaire. Vaccination data was collected from health passports, for those without health passports, data was collected using recall history. Regression analyses were used to test association between independent variables and full uptake of malaria vaccine.
Results
Uptake of malaria vaccine was 90.5% for dose 1, but reduced to 87.6%, 69.5% and 41.2% for dose 2, 3, and 4 respectively. Children of caregivers with secondary or upper education and those who attended antenatal clinic four times or more had increased odds of full uptake of malaria vaccine [OR: 2.43, 95%CI 1.08–6.51 and OR: 1.89, 95%CI 1.18–3.02], respectively. Children who ever suffered side-effects following immunization and those who travelled long distances to reach the vaccination centre had reduced odds of full uptake of malaria vaccine [OR: 0.35, 95%CI 0.06–0.25 and OR: 0.30, 95%CI 0.03–0.39] respectively. Only 17% (n = 65) of mothers/caregivers knew the correct schedule for vaccination and 38.5% (n = 158) knew the correct number of doses a child was to receive.
Conclusion
Only RTS,S dose 1 and 2 uptake met WHO coverage targets. Mothers/caregivers had low level of information regarding malaria vaccine, especially on numbers of doses to be received and dosing schedule. The primary modifiable factor influencing vaccine uptake was mother/caregiver knowledge about the vaccine. Thus, to increase the uptake Nsanje District Health Directorate should strengthen communities’ education about malaria vaccine. Programmes to strengthen mother/caregiver knowledge should be included in scale-up of the vaccine in Malawi and across sub-Saharan Africa.
Funder
European and Developing Countries Clinical Trials Partnership II
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. WHO. World malaria report. Geneva: World Health Organization; 2023.
2. WHO. Malaria: the malaria vaccine implementation programme (MVIP). Geneva: World Health Organization. 2023. https://www.who.int/news-room/questions-and-answers/item/malaria-vaccine-implementation-programme. Accessed 12 June 2022.
3. WHO. Full Evidence Report on the RTS,S/AS01 Malaria Vaccine. Geneva, World Health Organization, 2021. https://cdn.who.int/media/docs/default-source/immunization/mvip/full-evidence-report-on-the-rtss-as01-malaria-vaccine-for-sage-mpag. Accessed 8 Sept 2022.
4. Penny MA, Verity R, Bever CA, Saubouin C, Galactionova K, Flasche S, et al. Public health impact and cost-eff effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models. Lancet. 2016;387:367–75.
5. WHO. Business case for WHO immunization activities on the African continent. Geneva: World Health Organization; 2018.